Warren Buffett’s Berkshire Hathaway Inc. cut two of its payments bets -- holdings in $(Visa)$ Inc. and $(Mastercard)$ Inc. -- as it also pulled back on investments in pharmaceutical giants AbbVie Inc. and Bristol Myers-Squibb Co.
Berkshire reported a 30% decrease in AbbVie and a 16% cut to its Bristol-Myers Squibb investment during the third quarter, as well as no longer showing a stake in Merck & Co., according to a filing released Monday. The Visa and Mastercard holdings were cut 4.3% and 6% respectively.
精彩评论